A randomised phase II study: Treatment with daily p.o. Iressa (TM) (ZD1839) or placebo in combination with weekly IV infusion of docetaxel in patients with metastatic breast cancer
Latest Information Update: 27 Feb 2007
At a glance
- Drugs Docetaxel (Primary) ; Gefitinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 27 Feb 2007 Status change
- 24 Mar 2006 New trial record.